ArticleAnnals of gastroenterology

Dietary supplement based on dihydromyricetin in metabolic dysfunction-associated steatotic liver disease: a double-blind, placebo-controlled, randomized clinical trial.

Εlisavet Michailidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.